Latest Breaking News On - Kirti ganorkar - Page 1 : comparemela.com

Bayer and Sun Pharma sign marketing agreement for second brand of Finerenone in India

Bayer and Sun Pharma sign marketing agreement for second brand of Finerenone in India
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Shweta raiKirti ganorkarSun pharmaDrug administrationSun pharmaceutical industriesCountry division head for bayer pharmaceuticals businessMumbai based sun pharmaceutical industriesCountry division headPharmaceuticals businessSouth asiaEuropean commission

Bayer and Sun Pharma sign marketing and distribution agreement for second brand of cardiac drug in India

Bayer and Sun Pharma sign marketing and distribution agreement for second brand of cardiac drug in India
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

United statesShweta raiSun pharmaKirti ganorkarCountry division headSun pharmaceutical industriesAmerican diabetes associationDrug administrationBayer pharmaceuticals businessSun pharmaceutical industries limitedPharmaceuticals businessSouth asiaIndian chronic kidney diseaseIndia businessDiabetes associationEuropean commission

Sun Pharma-Bayer to market second brand of Finerenone in India

Sun Pharma-Bayer to market second brand of Finerenone in India
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Shweta raiKirti ganorkarSun pharmaSun pharmaceutical industriesBayer pharmaceuticals south asiaCountry division headChief executiveIndia businessBayer pharmaceuticalsSouth asiaIndian chronic kidney diseaseDrug administrationEuropean commission

Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease

Sun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights to Sun Pharma to distribute Finerenone under the brand name Lyvelsa. Sun Pharma CEO emphasizes commitment to providing innovative medicines to Indian patients.

New delhiSun pharmaKirti ganorkarPharma india businessSun pharma kidney

Sun Pharma & Bayer tie up to market new renal therapy

India Business News: Sun Pharma and Bayer have entered into an agreement to market and distribute a second brand of the patented medicine Finerenone in India. Finerenone i

Shweta raiKirti ganorkarSun pharmaCountry division head for bayerCountry division headSouth asiaBusiness newsRenal therapy